EMBECTA CORP
Embecta Corp (EMBC) is a healthcare company with a market capitalisation of about $836.3m that specialises in devices and consumables used in diabetes care. Investors should know it operates in a steady, necessity-driven market where product reliability, regulatory approvals and reimbursement matter. Growth may come from product innovation, expanding geographic reach and rising prevalence of diabetes, but margins and volume can be influenced by competition, pricing pressure and supply-chain costs. As a mid‑cap company, Embecta can offer upside if execution and adoption go well, yet it may also be more volatile than larger peers. Key considerations include product pipeline, manufacturing scale, regulatory pathway, and cash flow stability. This summary is educational and not personal financial advice: values can rise or fall and past performance is no guarantee of future returns. Investors should research company reports, check recent financials, and consider their own risk tolerance or consult a regulated adviser before acting.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding EMBECTA Corp's stock, with a target price indicating possible future growth.
Financial Health
Embecta Corp is performing well with solid revenue and cash flow, indicating strong business health.
Dividend
Embecta Corp's dividend yield of 5.08% is appealing for investors seeking dividend income. If you invested $1000 you would be paid $50.80 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring EMBC
At-Home Treatment Revolution | FDA Approval Impact
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug signals a major shift in chronic disease management. This creates an investment opportunity in companies that develop advanced drug delivery systems and support at-home patient care.
Published: September 1, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Diabetes device focus
The company operates in a steady, necessity-driven market where innovation and product reliability can support growth, though competitive pressure may affect returns.
Global market opportunity
Rising prevalence of diabetes worldwide can expand addressable markets, but regulatory and reimbursement differences across regions add complexity and risk.
Execution matters most
Manufacturing scale, regulatory milestones and supply‑chain resilience drive outcomes; investors should weigh these operational factors alongside financial metrics.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
